The abandoned controversy surrounding universal white blood cell reduction

Blood Transfusion

Volumn 12, Issue 2, 2014, Pages 143-145

  Vamvakas, Eleftherios C ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; BLOOD TRANSFUSION REACTION; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS INFECTION; EDITORIAL; ERYTHROCYTE TRANSFUSION; FEBRILE NON HEMOLYTIC TRANSFUSION REACTION; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; LEUKAPHERESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TRANSFUSION RELATED ACUTE LUNG INJURY; ECONOMICS; FEMALE; MALE; PROCEDURES;

ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE;

EID: 84899521936     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2014.0009-14     Document Type: Editorial

References (24)

1. Thurer RL, Luban NL, AuBuchon JP, et al. Universal WBC reduction. Transfusion 2000; 40: 751-2.
2. Tsantes AE, Kyriakou E, Nikolopoulos GK, et al. Cost-effectiveness of leucoreduction for prevention of febrile, non-haemolytic transfusion reactions. Blood Transfus 2014; 12: 232-7.
3. Vamvakas E, Blajchman MA. Transfusion-related immunomodulation: an update. Blood Rev 2007; 21: 327-48.
4. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513-6.
5. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Quist N. Randomized comparison of leukocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841-5. (Pubitemid 26320898)
6. Tartter PI, Mohandas K, Azar P, et al. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176: 462-6. (Pubitemid 29021548)
7. Bilgin YM, van de Watering LMG, Eijsman L, et al. Doubleblind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004; 109: 2755-60. (Pubitemid 38744552)
8. van de Watering LMG, Hermans J, Houbiers JGA, et al. Beneficial effect of leukocyte depletion of transfused blood on post-operative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97: 562-8. (Pubitemid 28090685)
9. Nathens AB, Nester TA, Rubenfeld GD, et al. The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock 2006; 26: 342-7. (Pubitemid 44402017)
10. Titlestad IL, Ebbesen LS, Ainsworth AP, et al. Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications: results of a double-blind, randomized study. Int J Colorectal Dis 2001; 16: 147-53. (Pubitemid 32591164)
11. Wallis JP, Chapman CE, Orr KE, et al. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002; 42: 1127-34.
12. van Hilten JA, van de Watering LMG, van Bockel JH, et al. Effects of transfusion with red cells filtered to remove leukocytes: Randomized controlled trial in patients undergoing major surgery. BMJ 2004; 328: 1281-4.
13. Boshkov LK, Furnary A, Morris C, et al. Prestorage leukoredution of red cells in elective cardiac surgery: results of a double-blind randomized controlled trial. Blood 2004; 104: 112a.
14. Houbiers JGA, Brand A, van de Watering LMG, et al. Randomized controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573-8. (Pubitemid 24267215)
15. Bracey AW, Radovancevick R, Nussimeier NA, et al. Leukocyte-reduced blood in open-heart surgery patients: effects on outcome. Transfusion 2002; 42 (Suppl): 5S.
16. Dzik WH, Anderson JK, O'Neill EM, et al. A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002; 42: 1114-22.
17. Nielsen HJ, Hammer J, Kraup AL, et al. Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substance accumulation in patients operated for burn trauma. Burns 1999; 25: 162-70.
18. Vamvakas EC. White-blood-cell containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis. Vox Sang 2007; 92: 224-32. (Pubitemid 46365029)
19. Bilgin YM, Brand A. Transfusion-related immunomodulation (TRIM): a second hit in an inflammatory cascade? Vox Sang 2008; 95: 261-71.
20. Vamvakas EC. Universal white-blood-cell reduction in Europe: has transmission of vCJD been prevented? Transfus Med Rev 2011; 25: 133-44.
21. Strong DM, Shoos Lipton K. Transfusion-related acute lung injury. AABB Association Bulletin #06-07 (November 3, 2006). Bethesda, MD: AABB, 2006. Available at: http://www.aabb.org/resources/publications/bulletins/Documents/ ab06-07.pdf. Accessed on 04/03/2014.
22. Dodd RY, Shoos Lipton K. Further guidance on methods to detect bacterial contamination of platelet components. AABB Association Bulletin #03-12 (October 1, 2003). Bethesda, MD: AABB, 2003. Available on http://www.aabb.org/resources/ publications/bulletins/Documents/ab03-14.pdf. Accessed on 04/03/2014.
23. Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 2010: 24: 77-124.
24. Vamvakas EC. Can policy decisions in transfusion medicine be evidence-based? In: Vamvakas EC. Decision-Making in Transfusion Medicine. Bethesda, MD: AABB Press, 2011, pp. 1-29.